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Background: Plasma levels of adiponectin which is secreted from adipose tissue are associated with various
parameters of metabolic syndrome. This effect seems to be a result of interactions between genetic and
environmental factors including central obesity. The present study was carried out to investigate the possibility of
relation between single nucleotide polymorphisms of adiponectin gene (+45 T/G and −11391 G/A) and waist
circumferences (WC) in patients with type 2 diabetes.
Methods: This cross-sectional study was conducted on n = 238 diabetic patients selected as cases and n = 159 as
healthy control who were recruited from Rafsanjan city in south – east of Iran. The possible association of +45 T/G
and –11391 G/A adiponectin gene polymorphisms with WC according to age and sex was evaluated.
Results: There was no significant difference in distribution of frequencies of +45 T/G and –11391 G/A adiponectin
gene polymorphisms in each group. We only found a significant association between –11391 G/A adiponectin
gene polymorphism with WC in diabetic group (p = 0.021). This association was remained significant after
adjustment in multivariate regression model (p = 0.019, OR: 0.244, 95%CI: 0.075-0.791) and also this effect was
independent of sex and age.
Conclusion: We found higher abdominal obesity in GA or AA carriers of adiponectin – 11391 G/A genotype in
type 2 diabetes patients independent of age and sex.
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Obesity and diet-dependent development of metabolic
syndrome are considered as a global health problem
[1,2]. Adiponectin is an adipokyne which is secreted
from exclusive differentiated adipose tissue and its
plasma level is reduced with increasing of body fat mass
[3,4]. It has metabolic effects on fat and glucose metab-
olism [5] besides anti inflammatory [3], and anti athero-
genic roles [6]. Adiponectin exhort its effects through
the sensitization of body to the insulin [7,8]. According
to the several studies, the plasma level of adiponectin
could be reduced in the animal models of obesity [9,10]
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distribution, and reproduction in any medium[11-13]. Reduction of adiponectin in plasma is
dependent on several factors such as reducing its pro-
duction or increasing its blood clearance by liver. In
addition to genetic factors which are influencing plasma
level of adiponectin, some environmental factors such as
consumption of the high-fat diet delays the clearance of
adiponectin from blood [14] while a rich carbohydrates
diet is associated with low levels of adiponectin [15]. In
a number of previous studies the relationship between
adiponectin genes single nucleotide polymorphisms
(SNPѕ) with serum adiponectin level have been reviewed
[16-18]. It is generally assumed that type 2 diabetes is
caused by both genetic disorder (SNPs) and environ-
mental factors including central obesity [19-21]. In pre-
vious reports the association between adiponectin gene
polymorphisms with incidence of type2 diabetes in lean
subjects was non-significant [22] , but the association
between adiponectin polymorphisms and type 2 diabetesCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Genotype frequencies of +45 T/G or −11391 G/A
in diabetic and non-diabetic groups
Variable Diabetics (n = 238) Non-diabetics (n = 159) P value
+45 TT 167 (42.4%) 107 (27.2%) 0.437
TG + GG 68 (17.3%) 52 (13.2%)
−11391 GG 221 (67.6%) 83 (25.4%) 0.809
GA + AA 16 (4.9%) 7 (2.1%)
P ≤ 0.05 is considered as significant in T-Test.
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morphisms within Adiponectin gene have been identi-
fied including polymorphisms at position −11391 G/A,
-11377 G/C, +45 T/G and 276 G/T [27] The goal of this
study was to examine the relation between two poly-
morphisms in adiponectin gene (+45 T/G and -11391
G/A) and type 2 diabetes in an Iranian population.
Methods
Study population
This was a case–control study. The case group included
238 patients with type 2 diabetes who were selected ran-
domly among patients referred to Rafsanjan diabetes
clinic. Control group were 159 healthy people who have
been chosen from the same population. (The sample of
the population is the same as previous studies from our
group) [23,28]. Diabetes diagnosis laid according to cri-
teria of America Diabetes association [29].
Data collection
After obtaining written consent from patients, a ques-
tionnaire comprising personal and demographic infor-
mation for each participant was completed. Waist
measurement was performed by a constant co-worker
by measuring the widest area which is located between
lower edge of lower rib and iliac crest and the unit was
centimeter. Abdominal obesity was considered as a wais
circumference over 90 cm. Waist circumference has
been considered as an index for abdominal obesity. In
this study, according to results of other studies which
were performed on Iranian population, measures more
than 90 cm were considered as abdominal obesity
[20,21,30-33]. 3-5 cc blood sample was taken from each
subject in tubes containing EDTA and Blood was stored
in 20°c. This study was approved by the research ethics
committee of Tehran University of Medical Sciences.
Genotyping
DNA extraction and molecular analysis of adiponectin
gene polymorphism: DNA was extracted from blood
samples which were collected in tubes containing EDTA
through salting out method. Molecular analysis of the
+45 T/G polymorphism was conducted by using the re-
port of Schaffer and his colleagues [34]. For molecular
analysis of −11391 G/A a PCR-RFLP assay was devel-





The PCR product was cut by MspI restriction enzyme .
Enzyme digestion lead to production of 137 and 26 basepairs (with A allele). Digestion products were visualized
on Agarose gel (%3.5) which was stained with ethidium
bromide Statistical analysis.
Statistical analysis
In this study, T-test, multivariate regression model,
POST-Hoc, chi- square and Software version 15 called
SPSS were used for data analysis ≤ 0.05 is considered as
a data with statistically significance.
Results
We recorded characteristics of 397 participants of whom
238 subjects suffered from diabetes. Majority of the par-
ticipants in diabetic group [170 (42.8%)] were females.
But in non-diabetic group 36 (9.1%) of participants were
female. Mean age of participants was 53 ± 10 and 50 ±
13 years in diabetic and non-diabetic group, respectively.
The mean ± SD for WC in diabetics was 91 ± 9 cm, and
in non-diabetics was 97 ± 11 cm. All of above analyses
had significant p values.
Genotype frequencies of +45 T/G or −11391 G/A for
our groups was shown in Table 1. The difference in fre-
quency of adiponectin +45 polymorphism in diabetic
and non diabetic cases based on waist circumference
was not statistically significant (Table 2). But these
results were varied for-11391 polymorphism that was
shown in Table 2. After adjusting for presence of dia-
betes, we observed that this significant difference was in-
dependent of sex and age in diabetics (Table 3).
Discussion
We found significantly increased abdominal obesity in
GA or AA carriers of adiponectin – 11391 G/A geno-
type in type 2 diabetes patients. This relation was inde-
pendent of age and sex. In a study on French population
the effects of adiponectin gene polymorphisms at posi-
tions (−11377C/G, -11391 G/A, +45 T/G, +276 G/T)
were examined with obesity and a strong relationship
between adiponectin polymorphisms and severe obesity
was observed. Furthermore, they found that haplotypes
associated with obesity were related to elevated levels of
plasma adiponectin, which indicates a relationship be-
tween hyper-adiponectinemia and weight gain [18]. It
has also been observed that −11391 G/A polymorphism
Table 2 The frequency of adiponectin +45 T/G or -11391 G/A genotype with waist circumference in an Iranian diabetic
and healthy population
Diabetic n (%) Non-diabetic n (%)
WC ≤ 90 WC > 90 Total WC > 90 WC ≤ 90 Total
TT 75 (32.2) 90 (38.6) 165(70.8) 23 (16.1) 77 (53.8) 100 (69.9)
+45 TG + GG 31 (13.3) 37 (15.9) 68 (29.2) 16 (11.2) 27 (18.9) 43 (30.1)
P = 0.985 P = 0.083
−11391 GG 95 (40.4) 124 (52.8) 219(93.2) 31(40.8) 40 (52.6) 71(93.4)
GA + AA 12 (5.1) 4(1.7) 16(6. 8) 2(2.6) 3(3.9) 5(6.6)
P = 0.021* P = 0.873
Legend: WC: Waist Circumference.
*P ≤ 0.05 in chi-square analysis test is considered as significant.
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obese children [18]. It has been proposed that −11391 A
allele might increase the ACDC adipocytes collagen
domain-containing activity [18]. In our previous study
we have found that the adiponectin −11391 A allele was
protective against weight gain only in the women and
adiponectin + 45 G allele was protective in both male
and female sex [23]. In another study on Danish popula-
tion the relation between -11391 G/A polymorphism
and abdominal obesity has been observed [26]. In one
study that performed in a Hispanic population, 18 differ-
ent adiponectin gene polymorphisms have been investi-
gated with regard to six different criteria for obesity
(BMI – Waist circumference - waist to hip ratio - sub-
cutaneous fat tissue-visceral fat-visceral fat to subcutane-
ous fat ratio) and among them, several polymorphisms
were related to obesity located in promoter region [35].
In a non-diabetic Korean population an association be-
tween +276 and +45 polymorphisms with serum adipo-
nectin, obesity and insulin resistance has been found
[24]. Also, they found a non significant association be-
tween +45 polymorphisms and WC. This finding is in
line with our finding especially for TT carriers of +45Table 3 Coefficients of multivariate regression model betwee
-11391 G/A genotype polymorphisms in diabetics
Variable
Sex (M/F)
Age (>40/≤ 40 yr)
TG + GG/TT polymorphisms of + 45 T/G genotype
GA + AA/GG polymorphisms of -11391 G/A genotype
Legend: F: female, M: male, WC: Waist Circumference, CI 95%: Confidence Interva
*P ≤ 0.05 in multivariate regression model is considered as significant.polymorphism and increased WC. Our results are
against the founding’s an study in Italian population
which observed a significant relationship between +276
and +45 polymorphisms with insulin resistance and
other related indicators such as WC (26). Also, in some
other studies, the linear relationship of plasma adiponec-
tin levels with waist circumference is totally obscured
[19,36].
Previous studies suggest that the relation between inci-
dence of type 2 diabetes and high blood pressure with
adiponectin genes polymorphism is depends on the pres-
ence of obesity. It means that these effects are less
observed in lean individuals who posses this polymorph-
ism [22]. However, we found higher WC in GA or AA
carriers of −11391 G/A polymorphism in diabetes group
and also this association was independent of age and sex.
Our data is in line with previous reports in French [18],
Danish [25] and Hispanic population [35]. However we
did not found association with +45 polymorphism and
abdominal obesity which confirms the previous report in
Korean [29] populations. Therefore, it seems that each
polymorphism in adiponectin gene is associated with
specific clinical phenotypes. In addition, discrepanciesn independent variables and adiponectin +45 T/G or
WC (>90/≤ 90 cm)
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action between different polymorphisms in various
conditions.
Finally it seems that more studies in a larger popula-
tion will be helpful to further confirm our Results. Also
study of other common polymorphisms in adiponectin
gene in Iranian population is recommended.
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